News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Nektar Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Beach
The Day In Review: Vertex Pharmaceuticals Incorporated Reveals Positive Hep C Data
May 22, 2006
·
1 min read
The Week In Review: From Optimism To Pessimism In Three Short Weeks
October 19, 2005
·
1 min read
Ten Drugs To Watch
October 19, 2005
·
3 min read
Bated Breath For Inhaled Insulin
October 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results
February 28, 2022
·
15 min read
Business
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2021 on Monday, February 28, 2022, After Close of U.S.-Based Financial Markets
February 17, 2022
·
1 min read
Biotech Bay
Nektar Therapeutics’ President and CEO, Howard Robin, to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
January 5, 2022
·
1 min read
Drug Development
Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis
December 15, 2021
·
8 min read
Drug Development
Nektar Therapeutics Presents Clinical Data for NKTR-255 in Patients with Relapsed/Refractory Hematologic Malignancies, Including Patients with Prior CAR-T Therapy, at the 63rd American Society of Hematology (ASH) Annual Meeting
December 13, 2021
·
8 min read
Biotech Bay
Nektar Therapeutics Announces Data Presentations for its Immuno-Oncology Programs at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2021 and the 63rd American Society of Hematology (ASH) Annual Meeting
November 30, 2021
·
7 min read
Business
Nektar Therapeutics Strengthens Board of Directors with Appointment of Diana M. Brainard, M.D.
November 15, 2021
·
2 min read
Biotech Bay
Nektar Therapeutics Announces Data Presentations for Its Immuno-Oncology Pipeline at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 12, 2021
·
10 min read
Biotech Bay
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Cancer Specialist During 2021 Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 9, 2021
·
6 min read
Business
Nektar Therapeutics Reports Third Quarter 2021 Financial Results
November 4, 2021
·
13 min read
